DE670160T1 - Ein Brausesystem und einen Arzneiwirkstoff enthaltendes granuläres Produkt bzw. Tablette sowie Verfahren zu deren Herstellung. - Google Patents
Ein Brausesystem und einen Arzneiwirkstoff enthaltendes granuläres Produkt bzw. Tablette sowie Verfahren zu deren Herstellung.Info
- Publication number
- DE670160T1 DE670160T1 DE0670160T DE94203112T DE670160T1 DE 670160 T1 DE670160 T1 DE 670160T1 DE 0670160 T DE0670160 T DE 0670160T DE 94203112 T DE94203112 T DE 94203112T DE 670160 T1 DE670160 T1 DE 670160T1
- Authority
- DE
- Germany
- Prior art keywords
- weight
- substance
- organic acid
- alkali
- carbonate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims 10
- 239000008186 active pharmaceutical agent Substances 0.000 title 1
- 239000000126 substance Substances 0.000 claims 28
- 239000000047 product Substances 0.000 claims 22
- 230000007935 neutral effect Effects 0.000 claims 21
- 239000003826 tablet Substances 0.000 claims 21
- 150000007524 organic acids Chemical class 0.000 claims 20
- 239000007787 solid Substances 0.000 claims 16
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims 15
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 claims 13
- 238000000576 coating method Methods 0.000 claims 13
- 239000003513 alkali Substances 0.000 claims 12
- 239000011248 coating agent Substances 0.000 claims 12
- 239000002253 acid Substances 0.000 claims 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 10
- 239000013543 active substance Substances 0.000 claims 10
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims 9
- 239000000203 mixture Substances 0.000 claims 9
- 239000002518 antifoaming agent Substances 0.000 claims 8
- 239000011230 binding agent Substances 0.000 claims 8
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims 7
- 239000013078 crystal Substances 0.000 claims 6
- 150000001720 carbohydrates Chemical class 0.000 claims 5
- 239000008187 granular material Substances 0.000 claims 5
- 239000000416 hydrocolloid Substances 0.000 claims 5
- 229920003169 water-soluble polymer Polymers 0.000 claims 5
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims 4
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims 4
- 229930195725 Mannitol Natural products 0.000 claims 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims 4
- 229910052783 alkali metal Inorganic materials 0.000 claims 4
- 150000001447 alkali salts Chemical class 0.000 claims 4
- 238000001035 drying Methods 0.000 claims 4
- 239000000796 flavoring agent Substances 0.000 claims 4
- 235000013355 food flavoring agent Nutrition 0.000 claims 4
- 235000003599 food sweetener Nutrition 0.000 claims 4
- 239000010410 layer Substances 0.000 claims 4
- 239000000594 mannitol Substances 0.000 claims 4
- 235000010355 mannitol Nutrition 0.000 claims 4
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims 4
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims 4
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 4
- 239000000243 solution Substances 0.000 claims 4
- 239000004094 surface-active agent Substances 0.000 claims 4
- 239000000375 suspending agent Substances 0.000 claims 4
- 239000003765 sweetening agent Substances 0.000 claims 4
- -1 alkali metal salt Chemical class 0.000 claims 3
- 229910052784 alkaline earth metal Inorganic materials 0.000 claims 3
- 239000007864 aqueous solution Substances 0.000 claims 3
- 239000007795 chemical reaction product Substances 0.000 claims 3
- 229960005132 cisapride Drugs 0.000 claims 3
- DCSUBABJRXZOMT-IRLDBZIGSA-N cisapride Chemical compound C([C@@H]([C@@H](CC1)NC(=O)C=2C(=CC(N)=C(Cl)C=2)OC)OC)N1CCCOC1=CC=C(F)C=C1 DCSUBABJRXZOMT-IRLDBZIGSA-N 0.000 claims 3
- DCSUBABJRXZOMT-UHFFFAOYSA-N cisapride Natural products C1CC(NC(=O)C=2C(=CC(N)=C(Cl)C=2)OC)C(OC)CN1CCCOC1=CC=C(F)C=C1 DCSUBABJRXZOMT-UHFFFAOYSA-N 0.000 claims 3
- 230000002209 hydrophobic effect Effects 0.000 claims 3
- 229910000029 sodium carbonate Inorganic materials 0.000 claims 3
- 239000002904 solvent Substances 0.000 claims 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 3
- CDOUZKKFHVEKRI-UHFFFAOYSA-N 3-bromo-n-[(prop-2-enoylamino)methyl]propanamide Chemical compound BrCCC(=O)NCNC(=O)C=C CDOUZKKFHVEKRI-UHFFFAOYSA-N 0.000 claims 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims 2
- 150000001342 alkaline earth metals Chemical class 0.000 claims 2
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 claims 2
- 235000013734 beta-carotene Nutrition 0.000 claims 2
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 claims 2
- 239000011648 beta-carotene Substances 0.000 claims 2
- 229960002747 betacarotene Drugs 0.000 claims 2
- 239000001569 carbon dioxide Substances 0.000 claims 2
- 229910002092 carbon dioxide Inorganic materials 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 229960001380 cimetidine Drugs 0.000 claims 2
- CCGSUNCLSOWKJO-UHFFFAOYSA-N cimetidine Chemical compound N#CNC(=N/C)\NCCSCC1=NC=N[C]1C CCGSUNCLSOWKJO-UHFFFAOYSA-N 0.000 claims 2
- 229940008099 dimethicone Drugs 0.000 claims 2
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims 2
- 239000004205 dimethyl polysiloxane Substances 0.000 claims 2
- 235000019329 dioctyl sodium sulphosuccinate Nutrition 0.000 claims 2
- AMTWCFIAVKBGOD-UHFFFAOYSA-N dioxosilane;methoxy-dimethyl-trimethylsilyloxysilane Chemical compound O=[Si]=O.CO[Si](C)(C)O[Si](C)(C)C AMTWCFIAVKBGOD-UHFFFAOYSA-N 0.000 claims 2
- 238000002156 mixing Methods 0.000 claims 2
- 239000002798 polar solvent Substances 0.000 claims 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims 2
- 229960000620 ranitidine Drugs 0.000 claims 2
- VMXUWOKSQNHOCA-LCYFTJDESA-N ranitidine Chemical compound [O-][N+](=O)/C=C(/NC)NCCSCC1=CC=C(CN(C)C)O1 VMXUWOKSQNHOCA-LCYFTJDESA-N 0.000 claims 2
- 229940083037 simethicone Drugs 0.000 claims 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims 2
- 235000017557 sodium bicarbonate Nutrition 0.000 claims 2
- 239000000600 sorbitol Substances 0.000 claims 2
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 claims 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims 1
- 229910002012 Aerosil® Inorganic materials 0.000 claims 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 claims 1
- 229940122957 Histamine H2 receptor antagonist Drugs 0.000 claims 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims 1
- 239000005913 Maltodextrin Substances 0.000 claims 1
- 229920002774 Maltodextrin Polymers 0.000 claims 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- 229910000288 alkali metal carbonate Inorganic materials 0.000 claims 1
- 150000008041 alkali metal carbonates Chemical class 0.000 claims 1
- 150000001340 alkali metals Chemical class 0.000 claims 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims 1
- 239000007900 aqueous suspension Substances 0.000 claims 1
- 235000010323 ascorbic acid Nutrition 0.000 claims 1
- 229960005070 ascorbic acid Drugs 0.000 claims 1
- 239000011668 ascorbic acid Substances 0.000 claims 1
- 239000000872 buffer Substances 0.000 claims 1
- 239000012928 buffer substance Substances 0.000 claims 1
- 238000002425 crystallisation Methods 0.000 claims 1
- 230000008025 crystallization Effects 0.000 claims 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 claims 1
- 238000004090 dissolution Methods 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000007938 effervescent tablet Substances 0.000 claims 1
- 238000001704 evaporation Methods 0.000 claims 1
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 claims 1
- 238000010438 heat treatment Methods 0.000 claims 1
- 239000011874 heated mixture Substances 0.000 claims 1
- 239000008101 lactose Substances 0.000 claims 1
- 239000001630 malic acid Substances 0.000 claims 1
- 235000011090 malic acid Nutrition 0.000 claims 1
- 229940035034 maltodextrin Drugs 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- 238000002844 melting Methods 0.000 claims 1
- 230000008018 melting Effects 0.000 claims 1
- HWPKGOGLCKPRLZ-UHFFFAOYSA-M monosodium citrate Chemical compound [Na+].OC(=O)CC(O)(C([O-])=O)CC(O)=O HWPKGOGLCKPRLZ-UHFFFAOYSA-M 0.000 claims 1
- 235000018342 monosodium citrate Nutrition 0.000 claims 1
- 239000002524 monosodium citrate Substances 0.000 claims 1
- 239000002245 particle Substances 0.000 claims 1
- 238000002161 passivation Methods 0.000 claims 1
- 229910000027 potassium carbonate Inorganic materials 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 229960001520 ranitidine hydrochloride Drugs 0.000 claims 1
- GGWBHVILAJZWKJ-KJEVSKRMSA-N ranitidine hydrochloride Chemical compound [H+].[Cl-].[O-][N+](=O)\C=C(/NC)NCCSCC1=CC=C(CN(C)C)O1 GGWBHVILAJZWKJ-KJEVSKRMSA-N 0.000 claims 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 claims 1
- 229910052938 sodium sulfate Inorganic materials 0.000 claims 1
- 235000011152 sodium sulphate Nutrition 0.000 claims 1
- 239000002344 surface layer Substances 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4406641 | 1994-03-01 | ||
| CH87394 | 1994-03-23 | ||
| EP94203112A EP0670160B1 (en) | 1994-03-01 | 1994-10-26 | Granular product or tablet containing an effervescent system and an active pharmaceutical substance, as well as a method for its preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE670160T1 true DE670160T1 (de) | 1996-03-14 |
Family
ID=27172490
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE0670160T Pending DE670160T1 (de) | 1994-03-01 | 1994-10-26 | Ein Brausesystem und einen Arzneiwirkstoff enthaltendes granuläres Produkt bzw. Tablette sowie Verfahren zu deren Herstellung. |
Country Status (15)
| Country | Link |
|---|---|
| JP (1) | JPH09509669A (zh) |
| CN (1) | CN1213739C (zh) |
| AU (1) | AU681256B2 (zh) |
| BR (1) | BR9506964A (zh) |
| CA (1) | CA2183952C (zh) |
| CZ (1) | CZ291710B6 (zh) |
| DE (1) | DE670160T1 (zh) |
| FI (1) | FI118033B (zh) |
| HU (1) | HU228147B1 (zh) |
| NO (1) | NO315308B1 (zh) |
| NZ (1) | NZ281228A (zh) |
| PL (1) | PL181714B1 (zh) |
| RU (1) | RU2153331C2 (zh) |
| TW (1) | TW403658B (zh) |
| WO (1) | WO1995023594A1 (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013083226A1 (de) * | 2011-12-09 | 2013-06-13 | Merck Patent Gmbh | Porenarmes, wasserfreies natriumcarbonat |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6489346B1 (en) | 1996-01-04 | 2002-12-03 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
| US5840737A (en) | 1996-01-04 | 1998-11-24 | The Curators Of The University Of Missouri | Omeprazole solution and method for using same |
| US20030070584A1 (en) | 2001-05-15 | 2003-04-17 | Cynthia Gulian | Dip coating compositions containing cellulose ethers |
| US8309118B2 (en) | 2001-09-28 | 2012-11-13 | Mcneil-Ppc, Inc. | Film forming compositions containing sucralose |
| DE10224607B4 (de) * | 2002-06-04 | 2008-03-13 | Lts Lohmann Therapie-Systeme Ag | Filmförmige, zerfallsfähige Zubereitungen zur Wirkstofffreisetzung und Verfahren zu deren Herstellung |
| WO2004050068A1 (en) | 2002-11-29 | 2004-06-17 | Janssen Pharmaceutica N.V. | Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base |
| US8993599B2 (en) | 2003-07-18 | 2015-03-31 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
| US8906940B2 (en) | 2004-05-25 | 2014-12-09 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
| US20080031942A1 (en) * | 2004-12-03 | 2008-02-07 | Takeda Pharmaceutical Company Limited | Solid Preparation |
| US8658208B2 (en) | 2010-02-26 | 2014-02-25 | Toray Industries, Inc. | Coated solid preparation |
| WO2014065890A1 (en) * | 2012-10-25 | 2014-05-01 | Otc Nutrition Llc | Fast dissolving solid calcium mineral supplement compositions and process of making |
| AU2013361760B2 (en) * | 2012-12-19 | 2018-07-05 | Bayer Animal Health Gmbh | Tablets with improved acceptance and good storage stability |
| CN105670003A (zh) * | 2014-11-21 | 2016-06-15 | 常州坤宇环保科技有限公司 | 高吸水树脂防结块剂 |
| EP3318135A1 (en) * | 2016-11-03 | 2018-05-09 | Perfetti Van Melle S.p.A. | Effervescent candy material, a process for its preparation and products made therefrom |
| WO2021076506A1 (en) * | 2019-10-17 | 2021-04-22 | Isp Investments Llc | A stable effervescent co-processed excipient composition and a process for preparing the same |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU1039170A (en) * | 1969-02-24 | 1971-07-22 | Abbott Laboratories | Tableting medium |
| US4704269A (en) * | 1985-06-11 | 1987-11-03 | Hudson Pharmaceutical Corporation | Effervescent antacid and analgesic compositions |
| CA2023493C (en) * | 1989-08-31 | 2000-01-04 | Masami Moroi | Composition for foaming preparation |
| DK0592484T3 (da) * | 1991-07-01 | 1995-06-12 | Gerhard Gergely | Brusetablet |
-
1994
- 1994-10-26 DE DE0670160T patent/DE670160T1/de active Pending
-
1995
- 1995-02-23 RU RU96120083/14A patent/RU2153331C2/ru not_active IP Right Cessation
- 1995-02-23 WO PCT/EP1995/000650 patent/WO1995023594A1/en active IP Right Grant
- 1995-02-23 HU HU9602380A patent/HU228147B1/hu not_active IP Right Cessation
- 1995-02-23 JP JP7522671A patent/JPH09509669A/ja active Pending
- 1995-02-23 BR BR9506964A patent/BR9506964A/pt not_active Application Discontinuation
- 1995-02-23 CN CN95191882.6A patent/CN1213739C/zh not_active Expired - Fee Related
- 1995-02-23 NZ NZ281228A patent/NZ281228A/en unknown
- 1995-02-23 CZ CZ19962519A patent/CZ291710B6/cs not_active IP Right Cessation
- 1995-02-23 CA CA002183952A patent/CA2183952C/en not_active Expired - Fee Related
- 1995-02-23 AU AU18114/95A patent/AU681256B2/en not_active Ceased
- 1995-03-01 TW TW084101871A patent/TW403658B/zh not_active IP Right Cessation
-
1996
- 1996-08-22 PL PL95316113A patent/PL181714B1/pl unknown
- 1996-08-28 NO NO19963588A patent/NO315308B1/no not_active IP Right Cessation
- 1996-08-30 FI FI963385A patent/FI118033B/fi not_active IP Right Cessation
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013083226A1 (de) * | 2011-12-09 | 2013-06-13 | Merck Patent Gmbh | Porenarmes, wasserfreies natriumcarbonat |
| US9388053B2 (en) | 2011-12-09 | 2016-07-12 | Merck Patent Gmbh | Anhydrous sodium carbonate having a low pore content |
Also Published As
| Publication number | Publication date |
|---|---|
| CA2183952C (en) | 2007-01-16 |
| FI963385A0 (fi) | 1996-08-30 |
| PL316113A1 (en) | 1996-12-23 |
| NO963588L (no) | 1996-10-31 |
| NO963588D0 (no) | 1996-08-28 |
| NO315308B1 (no) | 2003-08-18 |
| WO1995023594A1 (en) | 1995-09-08 |
| RU2153331C2 (ru) | 2000-07-27 |
| HUT75677A (en) | 1997-05-28 |
| CN1213739C (zh) | 2005-08-10 |
| AU1811495A (en) | 1995-09-18 |
| CA2183952A1 (en) | 1995-09-08 |
| TW403658B (en) | 2000-09-01 |
| PL181714B1 (en) | 2001-09-28 |
| FI118033B (fi) | 2007-06-15 |
| CZ251996A3 (en) | 1997-01-15 |
| HU9602380D0 (en) | 1996-10-28 |
| FI963385A (fi) | 1996-10-30 |
| NZ281228A (en) | 1997-06-24 |
| BR9506964A (pt) | 1997-09-09 |
| JPH09509669A (ja) | 1997-09-30 |
| HU228147B1 (en) | 2012-12-28 |
| AU681256B2 (en) | 1997-08-21 |
| CN1142182A (zh) | 1997-02-05 |
| CZ291710B6 (cs) | 2003-05-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3486409T2 (de) | Zusammensetzung zur kontrollierten Abgabe eines Wirkstoffs. | |
| EP0592484B1 (de) | Reaktionsdotierte brausesysteme | |
| DE670160T1 (de) | Ein Brausesystem und einen Arzneiwirkstoff enthaltendes granuläres Produkt bzw. Tablette sowie Verfahren zu deren Herstellung. | |
| DE69925016T2 (de) | Verbesserte tablette mit schneller auflösbarkeit | |
| DE69006365T2 (de) | Unbeschichtete pharmazeutische reaktionstablette. | |
| DE69821553T2 (de) | Granulatzubereitung enthaltend Simethicon und granuliertes wasserfreies Calciumphosphat | |
| EP0078430B1 (de) | Verfahren zur Herstellung von festen, schnellfreisetzenden Arzneizubereitungen mit Dihydropyridinen | |
| EP0804171B1 (de) | Kautablette mit brausewirkung | |
| DE69110592T2 (de) | Pharmazeutische Zubereitung mit verbessertem Geschmack, poröse Partikel enthaltend, und deren Herstellungsmethode. | |
| DE3701129A1 (de) | Verfahren zur herstellung von desinfizierend wirkenden kontaktlinsen-reinigungsmitteltabletten | |
| DE3024858A1 (de) | Anhaltend freigebende pharmazeutische zubereitung eines festen medikamentmaterials | |
| EP0181564A1 (de) | Pharmazeutische Zubereitung mit einem Gehalt an Ibuprofen, sowie Verfahren zu ihrer Herstellung | |
| DE2058434A1 (de) | Freifliessende,leicht benetzbare Acetylsalicylsaeure enthaltende Teilchen | |
| DE4444052A1 (de) | Pharmazeutische, oral anwendbare Zubereitung | |
| DE69718046T3 (de) | Direkt verpressbares lactitol und verfahren dazu | |
| DE4420735C2 (de) | Verfahren zur Herstellung mechanisch stabiler, sich mit hoher Auflösegeschwindigkeit auszeichnender Brausetabletten | |
| DD229030A5 (de) | Verfahren zur herstellung von tabletten mit regulierter wirkstoffabgabe | |
| EP0768868B1 (de) | Pharmazeutische zubereitung mit einem hydrophoben wirkstoff und einem brausesystem, sowie verfahren zur herstellung der zubereitung | |
| EP0911032B1 (de) | Brausezubereitung mit Pflanzenextrakt | |
| CH662926A5 (de) | Brausegemisch, insbesondere fuer brausetabletten, unter seiner verwendung hergestellte brausetabletten sowie verfahren zu seiner herstellung. | |
| DE69012932T2 (de) | Zubereitung für schäumendes Präparat. | |
| DE3142853C2 (zh) | ||
| EP0922450B1 (de) | Brausezubereitung enthaltend ein Pflanzenextrakt | |
| DE3632334C2 (zh) | ||
| DE3839825A1 (de) | Feststoffdispersionen enthaltend oxipurinol und/oder seine alkali- oder erdalkalisalze |